Trial Search Results

Ablation of Ventricular Fibrillation by Accurate Targeting of Arrhythmogenic Regions (AVATAR)

This study will test the hypothesis that many human heart rhythm disorders are caused by small localized sources, where brief ablation may successfully eliminate the heart rhythm disorder.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

University of California, San Diego

Stanford Investigator(s):


Inclusion Criteria:

   1. Documented ventricular tachyarrhythmias.

   2. Undergoing clinically indicated EP study with ablation.

Exclusion Criteria:

1. Unwillingness or inability to provide informed consent.

Ages Eligible for Study

21 Years - 90 Years

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305